JLB & Associates Inc. Has $1.86 Million Stock Holdings in Genpact Limited (NYSE:G)

JLB & Associates Inc. decreased its stake in shares of Genpact Limited (NYSE:GFree Report) by 31.1% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 36,836 shares of the business services provider’s stock after selling 16,644 shares during the quarter. JLB & Associates Inc.’s holdings in Genpact were worth $1,856,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in G. Coppell Advisory Solutions LLC grew its stake in shares of Genpact by 529.5% in the fourth quarter. Coppell Advisory Solutions LLC now owns 598 shares of the business services provider’s stock valued at $25,000 after buying an additional 503 shares in the last quarter. Atlas Capital Advisors Inc. lifted its stake in Genpact by 55.8% in the fourth quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider’s stock valued at $26,000 after acquiring an additional 216 shares during the last quarter. GeoWealth Management LLC grew its position in shares of Genpact by 199.0% in the 4th quarter. GeoWealth Management LLC now owns 876 shares of the business services provider’s stock valued at $38,000 after acquiring an additional 583 shares during the period. Smartleaf Asset Management LLC grew its position in shares of Genpact by 416.5% in the 4th quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider’s stock valued at $41,000 after acquiring an additional 783 shares during the period. Finally, J.Safra Asset Management Corp increased its stake in shares of Genpact by 38.8% during the 4th quarter. J.Safra Asset Management Corp now owns 1,622 shares of the business services provider’s stock worth $69,000 after purchasing an additional 453 shares during the last quarter. Institutional investors own 96.03% of the company’s stock.

Insider Buying and Selling

In other news, Director Nicholas C. Gangestad bought 2,000 shares of the company’s stock in a transaction dated Tuesday, May 13th. The stock was bought at an average cost of $43.97 per share, for a total transaction of $87,940.00. Following the transaction, the director now owns 2,000 shares of the company’s stock, valued at $87,940. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 3.07% of the stock is owned by insiders.

Genpact Trading Up 2.6%

Shares of NYSE:G opened at $44.03 on Tuesday. Genpact Limited has a 12-month low of $30.38 and a 12-month high of $56.76. The business has a 50 day moving average of $45.54 and a 200-day moving average of $47.12. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50. The stock has a market cap of $7.70 billion, a PE ratio of 15.50, a P/E/G ratio of 1.84 and a beta of 0.94.

Genpact (NYSE:GGet Free Report) last released its quarterly earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.04. Genpact had a return on equity of 22.50% and a net margin of 10.77%. The business had revenue of $1.21 billion during the quarter, compared to the consensus estimate of $1.21 billion. During the same period in the previous year, the company posted $0.73 EPS. The firm’s quarterly revenue was up 7.4% on a year-over-year basis. As a group, equities research analysts forecast that Genpact Limited will post 3.21 earnings per share for the current year.

Genpact Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Wednesday, June 18th will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 1.54%. The ex-dividend date of this dividend is Wednesday, June 18th. Genpact’s dividend payout ratio is 23.21%.

Analyst Ratings Changes

G has been the subject of several recent analyst reports. Wall Street Zen upgraded shares of Genpact from a “buy” rating to a “strong-buy” rating in a research note on Friday, June 6th. Needham & Company LLC cut their price objective on Genpact from $55.00 to $50.00 and set a “buy” rating for the company in a research report on Thursday, May 8th. Finally, Robert W. Baird reduced their target price on Genpact from $56.00 to $50.00 and set a “neutral” rating for the company in a research note on Thursday, May 8th. Four equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Genpact has a consensus rating of “Moderate Buy” and a consensus price target of $50.71.

View Our Latest Stock Report on G

Genpact Company Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

See Also

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:GFree Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.